Outperforming, favorite, and undervalued biotech firms

The Week in Review #28
The approval of revolutionary products created by biotech firms with solid scientific fundamentals, superior scientists and advanced technologies is what motivates us to pick for investment biotech and biopharmaceutical firms. So, let’s see what has been approved in the parting week  from firms that we picked for investment.      
Prohost Picked Firm    
Next Generation Sequencing    
The China National Drug Administration (CNDA) granted Illumina approval  for  its  MISeqDx  -­  a next-­generation  sequencing  system.  Illumina can now market and sell the MiSeqDx . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.